Publications
2023
The Impact of the COVID-19 Pandemic on Oral and Oropharyngeal Cancer
McIlvanna, E., McCarthy, C., & Gurzawska-Comis, K. (n.d.). The Impact of the COVID-19 Pandemic on Oral and Oropharyngeal Cancer. Current Oral Health Reports, 10(4), 154-162. doi:10.1007/s40496-023-00349-w
Oral cancer awareness and education within the pharmacy profession
Saadat, S., Longridge, N., Shaw, R., Walker, A., & McCarthy, C. (2023). Oral cancer awareness and education within the pharmacy profession. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 29(4), 826-832. doi:10.1177/10781552221081387
2022
The development of Proliferative Verrucous Leukoplakia on a background of oral lichen planus: A case series
McCarthy, C., Kazmi, A., Austin, T., Ho, M. W., Chengot, P., Rajlawat, B. P., . . . Field, A. (2022). The development of Proliferative Verrucous Leukoplakia on a background of oral lichen planus: A case series. Advances in Oral and Maxillofacial Surgery, 6, 100263. doi:10.1016/j.adoms.2022.100263
Enteral nutrition in the management of refractory orofacial Crohn disease
McCarthy, C., Finn, D., Rajlawat, B. P., & Yesudian, P. D. (2022). Enteral nutrition in the management of refractory orofacial Crohn disease. In BRITISH JOURNAL OF DERMATOLOGY Vol. 187 (pp. 197-198). Retrieved from https://www.webofscience.com/
Oral Medicine in Older People
Finn, D. J., McCarthy, C. E., & Rajlawat, B. P. (2022). Oral Medicine in Older People. In BDJ Clinician’s Guides (pp. 161-188). Springer International Publishing. doi:10.1007/978-3-031-10224-0_8
2021
Early-Phase Interventional Trials in Oral Cancer Prevention
McCarthy, C., Fedele, S., Ottensmeier, C., & Shaw, R. J. (2021). Early-Phase Interventional Trials in Oral Cancer Prevention. CANCERS, 13(15). doi:10.3390/cancers13153845
SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol
McCarthy, C., Sacco, J., Fedele, S., Ho, M., Porter, S., Liloglou, T., . . . Shaw, R. (2021). SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. TRIALS, 22(1). doi:10.1186/s13063-021-05373-8
Epigenetic Reprogramming in Oral Epithelial Dysplasia using Sodium Valproate: an in vitro study parallel to the SAVER trial
McCarthy, C. E., Liloglou, T., Hunter, K., & Shaw, R. J. (2021). Epigenetic Reprogramming in Oral Epithelial Dysplasia using Sodium Valproate: an in vitro study parallel to the SAVER trial. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 132(1), e28. doi:10.1016/j.oooo.2021.03.109
UK consensus recommendations on the management of oral epithelial dysplasia during COVID-19 pandemic outbreaks.
McCarthy, C. E., Fedele, S., Ho, M., & Shaw, R. (2021). UK consensus recommendations on the management of oral epithelial dysplasia during COVID-19 pandemic outbreaks.. Oral oncology, 112, 105110. doi:10.1016/j.oraloncology.2020.105110
2020
Development and validation of a multivariable risk prediction model for head and neck cancer using the UK Biobank
McCarthy, C. E., Bonnet, L. J., Marcus, M. W., & Field, J. K. (2020). Development and validation of a multivariable risk prediction model for head and neck cancer using the UK Biobank. INTERNATIONAL JOURNAL OF ONCOLOGY, 57(5), 1192-1202. doi:10.3892/ijo.2020.5123
2018
Solitary pigmentation of the tongue: lentigo simplex or pigmented fungiform papilla?
McCarthy, C., Holt, D., & Triantafyllou, A. (2018). Solitary pigmentation of the tongue: lentigo simplex or pigmented fungiform papilla?. Oral Surgery, 11(1), 50-54. doi:10.1111/ors.12264
Risk prediction modelling in head and neck cancer : development and validation of a model using the UK Biobank
McCarthy, C. (2018). Risk prediction modelling in head and neck cancer : development and validation of a model using the UK Biobank.
2017
Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review)
McCarthy, C. E., Field, J. K., & Marcus, M. W. (2017). Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review). ONCOLOGY REPORTS, 38(4), 1915-1922. doi:10.3892/or.2017.5867
DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity
Leung, E. Y., McMahon, J. D., McLellan, D. R., Syyed, N., McCarthy, C. E., Nixon, C., . . . Adams, P. D. (2017). DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity. HISTOPATHOLOGY, 71(4), 522-528. doi:10.1111/his.13260
Management of proliferative verrucous leukoplakia: Justification for a conservative approach.
Borgna, S. C., Clarke, P. T., Schache, A. G., Lowe, D., Ho, M. W., McCarthy, C. E., . . . Shaw, R. J. (2017). Management of proliferative verrucous leukoplakia: Justification for a conservative approach.. Head & neck, 39(10), 1997-2003. doi:10.1002/hed.24845
2016
Response to Oral epithelial dysplasia in oral submucous fibrosis: A challenge
Field, E. A., McCarthy, C. E., Ho, M. W., Rajlawat, B. P., Holt, D., Rogers, S. N., . . . Shaw, R. J. (2016). Response to Oral epithelial dysplasia in oral submucous fibrosis: A challenge. ORAL ONCOLOGY, 54, E20. doi:10.1016/j.oraloncology.2015.11.006
2015
The management of oral epithelial dysplasia: The Liverpool algorithm
Field, E. A., McCarthy, C. E., Ho, M. W., Rajlawat, B. P., Holt, D., Rogers, S. N., . . . Shaw, R. J. (2015). The management of oral epithelial dysplasia: The Liverpool algorithm. ORAL ONCOLOGY, 51(10), 883-887. doi:10.1016/j.oraloncology.2015.06.015
Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011
McCarthy, C. E., Field, J. K., Rajlawat, B. P., Field, A. E., & Marcus, M. W. (2015). Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011. INTERNATIONAL JOURNAL OF ONCOLOGY, 47(1), 204-210. doi:10.3892/ijo.2015.2990